Darcy Aba Quist

Ms. Darcy Aba Quist

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
KEKimimuepigha Ebisine
Kimimuepigha Ebisine
DQDarcy Aba Quist
Darcy Aba Quist
SFSTEPHEN FINDLAY-WILSON
STEPHEN FINDLAY-WILSON
EKEmma Kennedy
Emma Kennedy
SDStuart Dowall
Stuart Dowall
Rift Valley fever (RVF) is a mosquito-borne viral disease that primarily affects animals, especially ruminants, but has the capacity to infect humans and result in outbreaks. Infection with the causative agent, RVF virus (RVFV), causes severe disease in domestic animals, especially sheep, resulting in fever, anorexia, immobility, abortion, and high morbidity and mortality rates in neonate animals. Humans become infected through exposure to infected animals and, less frequently, directly via a mosquito bite. A greater awareness of RVFV and its epidemic potential has resulted in increased investment in the development of interventions, especially vaccines. There is currently no substitute for the use of animal models in order to evaluate these vaccines. As outbreaks of RVF disease are difficult to predict or model, conducting Phase III clinical trials will likely not be feasible. Therefore, representative animal model systems are essential for establishing efficacy data to support licensure. Nonhuman primate (NHP) species are often chosen due to their closeness to humans, reflecting similar susceptibility and disease kinetics. This review covers the use of NHP models in RVFV research, with much of the work having been conducted in rhesus macaques and common marmosets. The future direction of RVF work conducted in NHP is discussed in anticipation of the importance of it being a key element in the development and approval of a human vaccine.

9 February 2026 in Animal Models and Experimental Medicine
Verified
Journal Article
Open access
DQDarcy Aba Quist
Darcy Aba Quist
KEKimimuepigha Ebisine
Kimimuepigha Ebisine
EKEmma Kennedy
Emma Kennedy
SDStuart Dowall
Stuart Dowall
MDMike Dennis
Mike Dennis
Cynomolgus macaques, a species of Old World primate native to southeastern and eastern Asia and the island of Mauritius, are one of the most important nonhuman primate models for infectious disease. Although the closely related rhesus macaque is classified into subspecies based on geographic origin, no such subdivision exists for cynomolgus macaques, and they continue to be used interchangeably in infectious disease research, reducing the comparability of data produced from these studies. Research into the population genetics of cynomolgus macaques has found significant differences between macaques native to different areas, including their genetic diversity, with macaques from insular populations such as Mauritius and the Philippines exhibiting highly restricted heterozygosity compared to mainland populations native to Indonesia or Cambodia. In the context of infectious disease studies, research into pathogens, including Ebola virus, Crimean‐Congo hemorrhagic fever virus, and Mycobacterium tuberculosis have found differences in study outcomes, survival times, and immune cell responses between different populations of macaques. This review provides an overview of the differences between cynomolgus macaque populations in the context of genetic diversity, and in response to infection, and highlights the need for clear reporting of geographic origin of primates used in research. This will improve data comparison between studies and help to further refine this important animal model.